Početna › Limfom plaštanih stanica › Georgia
Kliničke studije za Limfom plaštanih stanica u državi Georgia
9 studija za Limfom plaštanih stanica traži sudionike na lokacijama u državi Georgia.
Gradovi u državi Georgia
Službeni tekst studije (engleski)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- Phoebe Putney Memorial Hospital, Albany
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- i još 4
U tijeku regrutacijaFaza 3
Od 60 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT05976763A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Augusta University, Augusta
- Southeastern Regional Medical Center, Newnan
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT05006716Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07003295DALY II USA/ MB-CART2019.1 for DLBCL
- Winship Cancer Institute of Emory University, Atlanta
- Georgia Cancer Center at Augusta University, Augusta
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT04792489Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 6. srp 2026. · NCT03501576A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Winship Cancer Institute of Emory University, Atlanta
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. srp 2026. · NCT05131022SynKIR-310 for Relapsed/Refractory B-NHL
- Winship Cancer Institute of Emory University, Atlanta
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 14. tra 2026. · NCT06544265Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
- Emory University Hospital/Winship Cancer Institute, Atlanta
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 9. velj 2026. · NCT04883437SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Atlanta
- Massive Bio SYNERGY-AI site, Savannah
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.